Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma

Hassan, Manal; Botrus, Gehan; Abdel-Wahab, Reham; Wolff, Robert; Li, Donghui; Tweardy, David; Phan, Alexandria; Hawk, Ernest; Javle, Milind; Lee, Ju-Seog; Torres, Harrys; Rashid, Asif; Lenzi, Renato; Hassabo, Hesham; Abaza, Yasmin; Shalaby, Ahmed; Lacin, ŞAHİN; Morris, Jeffrey; Patt, Yehuda; Amos, Christopher; Khaderi, Saira; Goss, John; Jalal, Prasun; Kaseb, Ahmed

doi:10.1016/j.cgh.2017.05.036

Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma

Atıf İçin Kopyala

Hassan M. M., Botrus G., Abdel-Wahab R., Wolff R. A., Li D., Tweardy D., ...Daha Fazla

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, cilt.15, sa.11, ss.1791-1799, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 15 Sayı: 11
Basım Tarihi: 2017
Doi Numarası: 10.1016/j.cgh.2017.05.036
Dergi Adı: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1791-1799
Hacettepe Üniversitesi Adresli: Evet

Özet

BACKGROUND & AIMS: Environmental factors have been identified that affect risk of hepatocellular carcinoma (HCC), but little is known about the effects of sex hormones on liver cancer development or outcome. The authors investigated whether menopause hormone therapy (MHT) affects risk, age at onset, or outcome of HCC.